Medicare PBM Accountability Act
This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.
Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.
In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2024-12-17 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2023-12-06 | Committee | Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0. | House committee actions |
| 2023-12-06 | Committee | Committee Consideration and Mark-up Session Held | House committee actions |
| 2023-12-05 | Committee | Committee Consideration and Mark-up Session Held | House committee actions |
| 2023-11-15 | Committee | Forwarded by Subcommittee to Full Committee by Voice Vote. | House committee actions |
| 2023-11-15 | Committee | Subcommittee Consideration and Mark-up Session Held | House committee actions |
| 2023-09-15 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2023-09-12 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2023-09-12 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2023-09-12 | IntroReferral | Introduced in House | Library of Congress |